186 related articles for article (PubMed ID: 28273347)
1. A phantom study: Should
Beijst C; de Keizer B; Lam MGEH; Janssens GO; Tytgat GAM; de Jong HWAM
Med Phys; 2017 May; 44(5):1624-1631. PubMed ID: 28273347
[TBL] [Abstract][Full Text] [Related]
2. Quantitative Comparison of 124I PET/CT and 131I SPECT/CT Detectability.
Beijst C; Kist JW; Elschot M; Viergever MA; Hoekstra OS; de Keizer B; de Jong HW
J Nucl Med; 2016 Jan; 57(1):103-8. PubMed ID: 26493205
[TBL] [Abstract][Full Text] [Related]
3. Whole-body PET/CT with 11C-meta-hydroxyephedrine in tumors of the sympathetic nervous system: feasibility study and comparison with 123I-MIBG SPECT/CT.
Franzius C; Hermann K; Weckesser M; Kopka K; Juergens KU; Vormoor J; Schober O
J Nucl Med; 2006 Oct; 47(10):1635-42. PubMed ID: 17015899
[TBL] [Abstract][Full Text] [Related]
4. Radiation dose estimation using preclinical imaging with 124I-metaiodobenzylguanidine (MIBG) PET.
Lee CL; Wahnishe H; Sayre GA; Cho HM; Kim HJ; Hernandez-Pampaloni M; Hawkins RA; Dannoon SF; VanBrocklin HF; Itsara M; Weiss WA; Yang X; Haas-Kogan DA; Matthay KK; Seo Y
Med Phys; 2010 Sep; 37(9):4861-7. PubMed ID: 20964203
[TBL] [Abstract][Full Text] [Related]
5. Simultaneous 99mTc-MDP/123I-MIBG tumor imaging using SPECT-CT: phantom and constructed patient studies.
Rakvongthai Y; El Fakhri G; Lim R; Bonab AA; Ouyang J
Med Phys; 2013 Oct; 40(10):102506. PubMed ID: 24089927
[TBL] [Abstract][Full Text] [Related]
6. Improvement in PET/CT image quality with a combination of point-spread function and time-of-flight in relation to reconstruction parameters.
Akamatsu G; Ishikawa K; Mitsumoto K; Taniguchi T; Ohya N; Baba S; Abe K; Sasaki M
J Nucl Med; 2012 Nov; 53(11):1716-22. PubMed ID: 22952340
[TBL] [Abstract][Full Text] [Related]
7. A blind deconvolution method incorporated with anatomical-based filtering for partial volume correction: Validations with
Wu J; Liu H; Hashemi Zonouz T; Sandoval VM; Mohy-Ud-Din H; Lampert RJ; Sinusas AJ; Liu C; Liu YH
Med Phys; 2017 Dec; 44(12):6435-6446. PubMed ID: 28994458
[TBL] [Abstract][Full Text] [Related]
8. Optimization of SPECT-CT Hybrid Imaging Using Iterative Image Reconstruction for Low-Dose CT: A Phantom Study.
Grosser OS; Kupitz D; Ruf J; Czuczwara D; Steffen IG; Furth C; Thormann M; Loewenthal D; Ricke J; Amthauer H
PLoS One; 2015; 10(9):e0138658. PubMed ID: 26390216
[TBL] [Abstract][Full Text] [Related]
9. [
Wang P; Li T; Liu Z; Jin M; Su Y; Zhang J; Jing H; Zhuang H; Li F
Eur J Nucl Med Mol Imaging; 2023 Aug; 50(10):3097-3106. PubMed ID: 37160439
[TBL] [Abstract][Full Text] [Related]
10. Equivalent Dose Rate 1 Meter from Neuroendocrine Tumor Patients Exiting the Nuclear Medicine Department After Undergoing Imaging.
Zhang-Yin J; Dirand AS; Sasanelli M; Corrégé G; Peudon A; Kiffel T; Nataf V; Clerc J; Montravers F; Talbot JN
J Nucl Med; 2017 Aug; 58(8):1230-1235. PubMed ID: 28209907
[No Abstract] [Full Text] [Related]
11. Prone-position acquisition of myocardial (123)I-metaiodobenzylguanidine (MIBG) SPECT reveals regional uptake similar to that found using (11)C-hydroxyephedrine PET/CT.
Yoshinaga K; Tomiyama Y; Manabe O; Kasai K; Katoh C; Magota K; Suzuki E; Nishijima K; Kuge Y; Ito YM; Tamaki N
Ann Nucl Med; 2014 Oct; 28(8):761-9. PubMed ID: 24950751
[TBL] [Abstract][Full Text] [Related]
12.
Aboian MS; Huang SY; Hernandez-Pampaloni M; Hawkins RA; VanBrocklin HF; Huh Y; Vo KT; Gustafson WC; Matthay KK; Seo Y
J Nucl Med; 2021 Jan; 62(1):43-47. PubMed ID: 32414950
[TBL] [Abstract][Full Text] [Related]
13. Comparison of 123I-MIBG SPECT-CT and 18F-DOPA PET-CT in the evaluation of patients with known or suspected recurrent paraganglioma.
Rufini V; Treglia G; Castaldi P; Perotti G; Calcagni ML; Corsello SM; Galli G; Fanti S; Giordano A
Nucl Med Commun; 2011 Jul; 32(7):575-82. PubMed ID: 21471850
[TBL] [Abstract][Full Text] [Related]
14. Prospective evaluation of 68Ga-DOTANOC positron emission tomography/computed tomography and 131I-meta-iodobenzylguanidine single-photon emission computed tomography/computed tomography in extra-adrenal paragangliomas, including uncommon primary sites and to define their diagnostic roles in current scenario.
Arora S; Kumar R; Passah A; Tripathi M; Agarwala S; Khadgawat R; Bal C
Nucl Med Commun; 2019 Dec; 40(12):1230-1242. PubMed ID: 31633647
[TBL] [Abstract][Full Text] [Related]
15. Is there a role for PET-CT and SPECT-CT in pediatric oncology?
Biermann M; Schwarzlmüller T; Fasmer KE; Reitan BC; Johnsen B; Rosendahl K
Acta Radiol; 2013 Nov; 54(9):1037-45. PubMed ID: 23319723
[TBL] [Abstract][Full Text] [Related]
16. Physical performance of the new hybrid PET∕CT Discovery-690.
Bettinardi V; Presotto L; Rapisarda E; Picchio M; Gianolli L; Gilardi MC
Med Phys; 2011 Oct; 38(10):5394-411. PubMed ID: 21992359
[TBL] [Abstract][Full Text] [Related]
17. [
Samim A; Blom T; Poot AJ; Windhorst AD; Fiocco M; Tolboom N; Braat AJAT; Viol SLM; van Rooij R; van Noesel MM; Lam MGEH; Tytgat GAM; de Keizer B
Eur J Nucl Med Mol Imaging; 2023 Mar; 50(4):1146-1157. PubMed ID: 36504277
[TBL] [Abstract][Full Text] [Related]
18. A NIM PET/CT phantom for evaluating the PET image quality of micro-lesions and the performance parameters of CT.
Lu S; Zhang P; Li C; Sun J; Liu W; Zhang P
BMC Med Imaging; 2021 Nov; 21(1):165. PubMed ID: 34749660
[TBL] [Abstract][Full Text] [Related]
19. Combining 123I-metaiodobenzylguanidine SPECT/CT and 18F-FDG PET/CT for the assessment of brown adipose tissue activity in humans during cold exposure.
Admiraal WM; Holleman F; Bahler L; Soeters MR; Hoekstra JB; Verberne HJ
J Nucl Med; 2013 Feb; 54(2):208-12. PubMed ID: 23318291
[TBL] [Abstract][Full Text] [Related]
20. Tumor dosimetry using [124I]m-iodobenzylguanidine microPET/CT for [131I]m-iodobenzylguanidine treatment of neuroblastoma in a murine xenograft model.
Seo Y; Gustafson WC; Dannoon SF; Nekritz EA; Lee CL; Murphy ST; VanBrocklin HF; Hernandez-Pampaloni M; Haas-Kogan DA; Weiss WA; Matthay KK
Mol Imaging Biol; 2012 Dec; 14(6):735-42. PubMed ID: 22382618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
